Comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'

Br J Cancer. 2014 Dec 9;111(12):2379-80. doi: 10.1038/bjc.2014.114. Epub 2014 Mar 11.

Authors

D Tougeron¹, P Laurent-Puig², A Zaanan³

Affiliations

¹ Department of Gastroenterology, Poitiers University Hospital, Poitiers, France.
² UMR-S775, INSERM, Paris, France.
³ 1] UMR-S775, INSERM, Paris, France [2] Department of Gastroenterology and Digestive Oncology, European Georges Pompidou University Hospital, AP-HP, Paris, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents, Phytogenic / therapeutic use*
Camptothecin / analogs & derivatives*
Colorectal Neoplasms / blood*
Colorectal Neoplasms / drug therapy*
DNA, Neoplasm / blood*
Female
Humans
Male
Proto-Oncogene Proteins / blood*
Proto-Oncogene Proteins / genetics*
ras Proteins / blood*
ras Proteins / genetics*

Substances

Antineoplastic Agents, Phytogenic
DNA, Neoplasm
Proto-Oncogene Proteins
ras Proteins
Camptothecin